Gufic Biosciences Board to recommend Dividend
Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 31, 2006, inter alia, to consider the approval of Audited Financial Results of the Company, and recommendation of Dividend if any for the financial year ended March 31, 2006. Gufic Biosciences - Fire at Navsari Bulk Drug Unit
Gufic Biosciences Ltd has informed BSE that the fire incident took place in one of the Company's Bulk Drug Unit at Navsari on April 22, 2006. The fire was controlled within a hour. There were no casualties reported. The preliminary damages will be assessed shortly. Gufic Biosciences - Acquisition of Manufacturing Unit
Gufic Biosciences Ltd has informed BSE that the Company is planning to buy a manufacturing unit at Haridwar or any other place which are recognised as Special Economic Zones, as part of its capacity expansion in the injectible segment.Further the Company has informed that the Company may make this information public through proper channels of communications, at appropriate time. Gufic Biosciences - Outcome of AGM
Gufic Biosciences Ltd has informed BSE that the members at the 21st Annual General Meeting (AGM) of the Company held on September 30, 2005, inter alia, have accorded to the following :1. Adoption of the Audited Balance Sheet as at March 31, 2005, the Profit and Loss Account for the year ended March 31, 2005 and the Reports of the Director's and the Auditor's thereon.... Gufic Biosciences fixes Book Closure
Gufic Biosciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2005 to September 30, 2005 (both days inclusive) for the purpose of Payment of Dividend and Annual General Meeting of the Company. Gufic Biosciences - Outcome of Board Meeting
Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 01, 2005, inter alia, has taken following decision :1. Declare the dividend @ 22% p.a. subject to the approval of the members of the Company.2. Approval of the draft notice of the Annual General Meeting of the Company, which will be held on September 30, 2005. Gufic Biosciences - Board Meeting, adjourned
Gufic Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company which was scheduled to be held on August 31, 2005, has been adjourned for want of quorum and will now be held on September 01, 2005. Gufic Biosciences Board to consider dividend
Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 31, 2005, inter alia, to consider the following:1. Annual Accounts of the Company for the year ended March 31, 2005 along with Auditors report and Director report thereon;2. Declare the dividend, if any;3. Approve the draft notice of the Annual General Meeting;4. Fix the day, date and time of the Annual General Meeting. Gufic Biosciences to make foray into "anticancer products"
Gufic Biosciences Ltd has informed BSE that the Company is all set to make foray into "anticancer products". Research & Development has always been the Company's core strength. Currently, the Company is in advanced stage of development of range of anticancer products, which are in lyophilized form. These products are going to be a major import substitute for Indian patients, thus making the medicine affordable. There are very few players in Indian... Gufic Biosciences emerging as strong player in Biotechnology
Gufic Biosciences Ltd has informed BSE that the Company is emerging as a strong player in the area of biotechnology having manufactured many biotech products in the area of infertility and bleeding disorder.The Company is now launching streptokinase and urokinase. These two thrombolytic products have very good potential in Indian market. The Company has also tied up with some other Indian companies for marketing of these products....